Ivabradine treatment for an infant with potential accessory pathway-related refractory supraventricular tachycardia
CARDIOLOGY IN THE YOUNG, vol.35, no.6, pp.1266-1269, 2025 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 35 Issue: 6
- Publication Date: 2025
- Doi Number: 10.1017/s1047951125001945
- Journal Name: CARDIOLOGY IN THE YOUNG
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
- Page Numbers: pp.1266-1269
- Keywords: children, Ivabradine, supraventricular tachycardia
- Eskisehir Osmangazi University Affiliated: Yes
Abstract
Ivabradine has been shown to be safe and effective in treating congenital and postoperative junctional ectopic tachycardia in children; however, in recent years, case reports have suggested that it may also be used to treat automaticity-related ectopic atrial tachycardia and focal atrial tachycardia. Here, we discussed a case in which we used ivabradine to induce sinus rhythm in a 38-day-old baby who had resistant supraventricular tachycardia and investigated potential accessory pathway-related tachycardia.